drugset / Trial / NCT00192673
Poly(Ethylene Glycol)(PEG)-Asparaginase During Two Treatment Courses
Phase 4
Unknown
85 enrolled
Nordic Society for Pediatric Hematology and Oncology
Danish Child Cancer Foundation · collabMedac, Hamburg, Germany · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is 1. to determine the correct dose for intramuscular administration 2. to compare the frequency of antibody formation after intramuscular administration of native E.coli asparaginase and PEG-asparaginase during two treatment courses in the treatment of childhood lymphoblastic leukemia
Timeline
- Start
- 2005-06
- Primary completion
- —
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pegaspargase | Protein / enzyme biologic | — | Intramuscular |